Endocrine conditions associated with MAFLD include polycystic ovarian syndrome, hypothyroidism, and GH deficiency
Renuvion: Scarless Skin Tightening After GLP-1 Weight Loss For patients with mild to moderate skin laxity, theres now a cutting-edge alternativeRenuvion
GLP-1 patches don't contain any GLP-1, they haven't been clinically approved, and there's no strong evidence that they lead to meaningful weight loss
Someone with a rough run of GI side effects needs an earlier kidney and electrolyte check
Because retatrutide is still in clinical trials, its long-term side effects are not yet fully known
Genetic testing through the Precision Peptide panel becomes available as a $99 add-on after your first month of treatment, allowing providers to refine therapy based on your unique peptide architecture